OSSMAR: An Observational Study to Describe the Use of Sunitinib in Real-Life Practice for the Treatment of Metastatic Renal Cell Carcinoma

by Marwan Ghosn, Roland Eid, Emad Hamada, Hamdy Abdel Azim, Jamal Zekri, Mubarak Al-Mansour, Mohammed Jaloudi, Fadi Nasr, Hassan Errihani, Adda Bounedjar, Amel Mezlini, Hamouda Boussen, Joseph Kattan, Fadi El Karak, Fadi Farhat, on behalf of the Africa Middle East Cancer Intergroup
Published 2019-10-01